Solu Therapeutics

Boston, MA · Founded 2022 · Privately Held (backing)

Developer of bifunctional small-molecule therapeutics designed to eliminate disease-driving cells. Solu Therapeutics is based in Boston, MA and was founded in 2022. Its last reported valuation was $104 million in Apr 2025. It has raised $72 million.

Last reported valuation

$104.0M

Oct 2026

Priced at

—

Total raised

$72.0M

Last round

—

How much has Solu Therapeutics raised?

$72.0Macross 0 recorded rounds

Free account

More of Solu Therapeutics with a free account

·The complete investor list: 11 names
·Watch Solu Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Solu Therapeutics investors

11 investors are on record for Solu Therapeutics, including Alexandria Venture Investments, DCVC Bio, Astellas Venture Management and Biovision Ventures.

For fundraisers

Raising for a company like Solu Therapeutics?

11 investors have backed Solu Therapeutics.

See all 11 investors →

Frequently asked about Solu Therapeutics

How much has Solu Therapeutics raised?: Solu Therapeutics has raised $72.0M in total across 0 recorded funding rounds.